9SB.F - SOL Global Investments Corp.

Frankfurt - Frankfurt Delayed Price. Currency in EUR
1.5460
-0.0380 (-2.40%)
As of 8:15AM CEST. Market open.
Stock chart is not supported by your current browser
Previous Close1.5840
Open1.5460
Bid1.5470 x 0
Ask1.6370 x 0
Day's Range1.5460 - 1.5460
52 Week Range0.7320 - 3.6800
Volume2,000
Avg. Volume74
Market Cap72.573M
Beta (3Y Monthly)N/A
PE Ratio (TTM)0.38
EPS (TTM)4.0340
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • SOL Global Adds California to Its MSO Portfolio with Proposed Acquisition of Premiere Cultivation, Processing, and Dispensary Companies
    CNW Group6 days ago

    SOL Global Adds California to Its MSO Portfolio with Proposed Acquisition of Premiere Cultivation, Processing, and Dispensary Companies

    TORONTO , May 16, 2019 /CNW/ - SOL Global Investments Corp. ("SOL Global" or the "Company") (SOL.CN) (SOLCF) (9SB.F) is pleased to announce that it has entered into letters of intent to acquire ECD, Inc., which operates as Northern Emeralds ("Northern Emeralds"), an industry leading cannabis cultivation, processing and distribution company headquartered in Humboldt County, California , as well as six (6) licensed dispensary companies in California that will subsequently operate under the nationally recognized "One Plant" brand. SOL Global intends to open One Plant -branded dispensaries throughout California (a total of 20 operating and licensed dispensary companies), Florida , and Michigan .

  • SOL Global Signs Binding Agreement with Merida Capital Partners' Subsidiary to Acquire Michigan Fully Licensed Cannabis Business
    CNW Group28 days ago

    SOL Global Signs Binding Agreement with Merida Capital Partners' Subsidiary to Acquire Michigan Fully Licensed Cannabis Business

    TORONTO , April 24, 2019 /CNW/ - SOL Global Investments Corp. ("SOL Global" or the "Company") (SOL.CN) (SOLCF) (9SB.F), the owner of 3 Boys Farms, LLC ("3 Boys"), which holds one of Florida's original 14 operating and vertically integrated medical marijuana treatment center licenses, is pleased to announce that it has entered into a binding letter of intent ("LOI") with cannabis-focused private equity firm Merida Capital Partners ("Merida") dated April 23, 2019 to acquire Merida's Michigan subsidiary, MCP Wellness, Inc. ("MCP Wellness") for an aggregate purchase price of US$150 million (the "Acquisition"). MCP Wellness, a special-purpose vehicle (SPV) created to invest in Michigan cannabis operations, currently holds the rights to acquire two Michigan cultivation licenses, a processing license, and 3 fully licensed cannabis provisioning centers in Michigan with a fourth provisioning center scheduled to open in Ann Arbor in May.

  • SOL Global Announces 3 Boys Farms' Receipt of Approval to Dispense Cannabis Flower and Pre-Roll Products in Florida
    CNW Grouplast month

    SOL Global Announces 3 Boys Farms' Receipt of Approval to Dispense Cannabis Flower and Pre-Roll Products in Florida

    TORONTO , April 22, 2019 /CNW/ - SOL Global Investments Corp. ("SOL Global" or the "Company") (SOL.CN) (SOLCF) (9SB.F) is pleased to announce that 3 Boys Farms, LLC ("3 Boys Farm"), which owns and operates one of the twenty-two (22) medical marijuana treatment center licenses in Florida , has received approval from the State of Florida's Department of Health, Office of Medical Marijuana Use ("OMMU") to begin dispensing its premium, organically cultivated cannabis flower and pre-rolled products at its new state-of-the-art extraction and processing facility in Indiantown, Florida . SOL Global completed its acquisition of 3 Boys Farms earlier this month through the closing of its purchase of CannCure Investments Inc.

  • SOL Global's CBD and Hemp Portfolio Company, Heavenly Rx, Closes Private Placement Financing of Over $12 Million
    CNW Grouplast month

    SOL Global's CBD and Hemp Portfolio Company, Heavenly Rx, Closes Private Placement Financing of Over $12 Million

    TORONTO , April 18, 2019 /CNW/ - SOL Global Investments Corp. ("SOL Global" or the "Company") (SOL.CN) (SOLCF) (9SB.F) is pleased to announce that it has completed multiple tranches of a non-brokered private placement financing of common shares of its subsidiary, Heavenly Rx Ltd. ("Heavenly Rx"), for aggregate gross proceeds of $12,586,250 (the "Offering"). An aggregate of 125,862,500 common shares in the capital of Heavenly Rx ("Heavenly Shares") were issued and sold at a price of $0.10 per Heavenly Share. As a result of this financing, SOL Global now holds 34.40% of the issued and outstanding Heavenly Shares with the subscribers from the Offering collectively holding the remaining 65.60%.

  • SOL Global Completes Acquisition of 3 Boys Farms through the Purchase of CannCure Investments Inc.
    CNW Grouplast month

    SOL Global Completes Acquisition of 3 Boys Farms through the Purchase of CannCure Investments Inc.

    Pursuant to the terms of an amended and restated share purchase agreement (the "Amended Purchase Agreement") between the Company, CannCure and the shareholders of CannCure (the "Sellers"), SOL Global acquired all of the issued and outstanding common shares of CannCure for a revised purchase price of US$41,207,519 , which was partially satisfied by the issuance of 7,317,500 common shares of SOL Global ("Consideration Shares") at a negotiated price of CAD $4.00 per share to the Sellers on a pro-rata basis.

  • GlobeNewswirelast month

    Exactus Applauds Executive Chairman, Jonathan Gilbert on Launch of Impact Biosciences Corp.

    Exactus Inc. (EXDI), a healthcare company pursuing opportunities in Hemp derived Cannabidiol (CBD) products, applauds its Executive Chairman of the Board, Jonathan Gilbert, on the launch of Impact Biosciences Corp. Jonathan Gilbert, cannabis industry veteran, and founder and former CEO of SOL Global Investments Corp. (CSE:SOL) (9SB.F) (SOLCF), whose wholly owned subsidiary, Scythian Biosciences Inc. (“SBI”), is seeking to list SBI as a new public company on the Canadian Stock Exchange (“CSE”) following a successful capital raise and spinout.

  • SOL Global to Spin Off Cannabinoid Drug Therapy Research and Development Subsidiary
    CNW Group2 months ago

    SOL Global to Spin Off Cannabinoid Drug Therapy Research and Development Subsidiary

    TORONTO , April 5, 2019 /CNW/ - SOL Global Investments Corp. ("SOL" or the "Company") (SOL.CN) (9SB.F) (SOLCF)  is pleased to announce that it intends to spin off its wholly-owned subsidiary, Scythian Biosciences Inc. ("SBI"), into an independent, publicly-traded company (the "Spin-off"). In connection with the Spin-off, SBI will be renamed "Impact Biosciences Corp" ("Impact") and will continue to pursue a drug development in the United States for the treatment of concussions and traumatic brain injury with its proprietary Cannabinoid combination drug candidate, which is being developed under contract with the University of Miami . Impact's mission is to become the first accepted drug regimen for concussive treatment.

  • SOL Global Announces 3 Boys Farms' Receipt of Approval for Cannabis Processing and Dispensing in State of Florida
    CNW Group2 months ago

    SOL Global Announces 3 Boys Farms' Receipt of Approval for Cannabis Processing and Dispensing in State of Florida

    TORONTO , April 3, 2019 /CNW/ - SOL Global Investments Corp. ("SOL Global" or the "Company") (SOL.CN) (SOLCF) (9SB.F) is pleased to announce that 3 Boys Farms, LLC ("3 Boys Farm"), which owns and operates one of the fourteen medical marijuana treatment center licenses in Florida , has received approval from the State of Florida's Department of Health, Office of Medical Marijuana Use ("OMMU") to begin processing and dispensing cannabis products at its new state-of-the-art extraction and processing facility in Indiantown, Florida . SOL Global is in the process of acquiring 3 Boys Farms through its previously announced acquisition of CannCure Investments Inc. ("Canncure") pursuant to a binding share purchase agreement.

  • SOL Global Acquires 10.3 Percent Stake in Premium Beauty and Wellness Company Sacred Hemp
    CNW Group2 months ago

    SOL Global Acquires 10.3 Percent Stake in Premium Beauty and Wellness Company Sacred Hemp

    TORONTO , April 2, 2019 /CNW/ - SOL Global Investments Corp. ("SOL Global" or the "Company") (SOL.CN) (SOLCF) (9SB.F) is pleased to announce its latest strategic investment, a significant position in premium hemp company Sacred Hemp ("Sacred"). SOL Global has acquired a 10.3 percent stake in Sacred, the Chicago, Illinois -based manufacturer of premium hempseed oil-infused products including pain relief balms and oils, feminine products, massage oils, salt soaks, and personal lubricants. Sacred's product line includes its bestselling all-natural pain relief balms and lotions, made from a combination of natural hempseed oil extracts, essential oils, and menthol.

  • SOL Global Signs Termination Agreement with Verano Holdings over Sale of 3 Boys Farms
    CNW Group2 months ago

    SOL Global Signs Termination Agreement with Verano Holdings over Sale of 3 Boys Farms

    TORONTO , April 1, 2019 /CNW/ - SOL Global Investments Corp. ("SOL Global" or the "Company") (SOL.CN) (SOLCF) (9SB.F) announces the termination of its agreement with Verano Holdings, LLC ("Verano") to sell a 100% interest in 3 Boys Farms LLC ("3 Boys Farms"), a Florida -licensed medical cannabis company which SOL Global was in the process of acquiring, to Verano. As announced on October 23, 2018 , the Company had entered into a binding contribution agreement to sell a 100% interest in 3 Boys Farms, which included 100% ownership in one of Florida's fourteen (14) vertically integrated medical cannabis licenses to Verano in exchange for USD$100 million of Class B units in Verano.

  • SOL Global Increases Stake in Jones Soda to 9.8 Percent
    CNW Group2 months ago

    SOL Global Increases Stake in Jones Soda to 9.8 Percent

    TORONTO , March 28, 2019 /CNW/ - SOL Global Investments Corp. ("SOL Global" or the "Company") (SOL.CN) (SOLCF) (9SB.F) is pleased to announce it has increased its investment in premium soda-maker Jones Soda Co. (" Jones Soda ") (JSDA). SOL Global has acquired a total of 4,066,048 common shares of Jones Soda , or approximately 9.8 percent of the total issued and outstanding common shares of Jones Soda . SOL Global has filed an amendment to the Schedule 13D that the Company had previously filed with the United States Securities and Exchange Commission describing its additional investment in Jones Soda .

  • SOL Global Acquires 8 Percent Stake in Iconic Soda Company Jones Soda
    CNW Group2 months ago

    SOL Global Acquires 8 Percent Stake in Iconic Soda Company Jones Soda

    TORONTO , March 26, 2019 /CNW/ - SOL Global Investments Corp. ("SOL Global" or the "Company") (SOL.CN) (SOLCF) (9SB.F) is pleased to announce its investment in leading premium soda-maker Jones Soda Co. (" Jones Soda ") (JSDA). SOL Global has acquired 3,396,049 common shares of Jones Soda in the open market. SOL Global's total investment represents approximately 8.19% of the total issued and outstanding common shares of Jones Soda which, based on publicly available information, makes it the company's largest stockholder.

  • SOL Global Announces Receipt of Approval for Sale and Transfer of Florida 3 Boys Farms Operations and Assets
    CNW Group2 months ago

    SOL Global Announces Receipt of Approval for Sale and Transfer of Florida 3 Boys Farms Operations and Assets

    TORONTO , March 11, 2019 /CNW/ - SOL Global Investments Corp. ("SOL Global" or the "Company") (SOL.CN) (SOLCF) (9SB.F) is excited to announce that the Company has received approval from the Florida Department of Health for the sale and transfer of the 3 Boys Farm ("3 Boys") license from CannCure Investments Inc. ("CannCure") to SOL Global. The approval includes the transfer of all operations and assets, including farms and dispensaries.

  • SOL Global Subsidiary Heavenly Rx Announces Acquisition of 568 Acres of Hemp Farms for Biomass Production
    CNW Group2 months ago

    SOL Global Subsidiary Heavenly Rx Announces Acquisition of 568 Acres of Hemp Farms for Biomass Production

    TORONTO , March 7, 2019 /CNW/ - SOL Global Investments Corp. ("SOL Global" or the "Company") (SOL.CN) (SOLCF) (9SB.F) is pleased to announce that it has signed a binding letter of intent ("LOI") to acquire three tracts of agricultural property totaling 568 acres of land in the States of Tennessee and Kentucky for the cultivation and production of raw hemp biomass. The Company will assign the agricultural property to its hemp/CBD-focused subsidiary, Heavenly Rx Ltd. ("Heavenly").

  • CNW Group3 months ago

    SOL Global Provides Update on Groundbreaking Achievement Made by Its European Strategic Investment European Cannabis Holdings

    TORONTO , March 4, 2019 /CNW/ - SOL Global Investments Corp. ("SOL Global" or the "Company") (CSE:SOL) (SOLCF) (9SB.F) is pleased to provide an update on the operations of one of its significant international investments, European Cannabis Holdings ("ECH"). In February 2019 , ECH celebrated a historic milestone by becoming the first company in the United Kingdom to facilitate the importation of a bulk shipment of medical cannabis.

  • CNW Group3 months ago

    SOL Global Announces Results for the Three and Nine-Month Period Ended December 31, 2018

    TORONTO , March 1, 2019 /CNW/ - SOL Global Investments Corp. ("SOL Global" or the "Company") (CSE:SOL) (SOLCF) (9SB.F) is pleased to release its financial results for the three and nine months ended December 31, 2018 , and provide a general corporate update, including a management-prepared internal net asset value calculation. The Company's unaudited condensed interim consolidated financial statements and Management's Discussion and Analysis (the "MD&A") for the three and nine months ended December 31, 2018 are also provided herein.  All financial information in this press release is reported in Canadian dollars, unless otherwise indicated. " Sunday, March 3 will mark four months since I was appointed as CEO of SOL Global.

  • SOL Global Announces Completion of Investment in European Cannabis Holdings
    CNW Group3 months ago

    SOL Global Announces Completion of Investment in European Cannabis Holdings

    TORONTO , Feb. 27, 2019 /CNW/ - SOL Global Investments Corp. ("SOL Global" or the "Company") (CSE:SOL) (SOLCF) (9SB.F) is pleased to announce the close of its latest investment in European Cannabis Holdings ("ECH"), a group of companies helping to shape the future of cannabis in Europe .

  • SOL Global Announces Formation of International Hemp Company Heavenly Rx
    CNW Group3 months ago

    SOL Global Announces Formation of International Hemp Company Heavenly Rx

    TORONTO , Feb. 25, 2019 /CNW/ - SOL Global Investments Corp. ("SOL Global" or the "Company") (CSE:SOL) (SOLCF) (9SB.F) is pleased to announce the formation of a new international hemp-focused subsidiary, Heavenly Rx Ltd. ("Heavenly Rx"). Heavenly Rx intends to hold controlling ownership interests in various industry-leading assets in the hemp/CBD and THC-free cannabinoid wellness space, with an initial focus on hemp cultivation, processing and the manufacturing of a diverse range of traditional CBD products including oils, tinctures, balms, and vape-ready products. Additionally, Heavenly Rx intends to include several proprietary brands across numerous consumer product group verticals such as cosmetics and beauty products, bath and body products, infused foods (subject to governmental approvals and/or compliance) and a number of pet-related products.

  • CNW Group4 months ago

    SOL Global Investments Announces Voting Results from the Annual and Special Meeting of Shareholders

    The approval of the change of business of the Company from a "life sciences issuer" to an "investment company" as those terms are used in the policies of the Canadian Securities Exchange with over 99% of the shares represented at the meeting, representing both a simple majority and a majority excluding the shares of the insiders of the Company, voting in favour.

  • SOL Global Announces Completion of Normal Course Issuer Bid for Purchase of 5% of Company's Common Shares
    CNW Group4 months ago

    SOL Global Announces Completion of Normal Course Issuer Bid for Purchase of 5% of Company's Common Shares

    TORONTO , Jan. 8, 2019 /CNW/ - SOL Global Investments Corp. ("SOL Global" or the "Company") (SOL.CN) (SOLCF) (9SB.F) is pleased to announce the completion of its normal course issuer bid ("NCIB") for the purchase of 2,451,861 of the Company's common shares, representing approximately 5% of its issued and outstanding common shares at the time of the commencement of the NCIB. The shares were purchased through the facilities of the Canadian Securities Exchange at an average purchase price of $2.00 per share.

  • SOL Global Announces Investment in and Strategic Partnership with European Medical Cannabis and CBD Firm GreenLight Pharmaceuticals Ltd.
    CNW Group5 months ago

    SOL Global Announces Investment in and Strategic Partnership with European Medical Cannabis and CBD Firm GreenLight Pharmaceuticals Ltd.

    TORONTO , Jan. 2, 2018 /CNW/ - SOL Global Investments Corp. ("SOL Global" or the "Company") (SOL.CN) (9SB.F) (SOLCF) is pleased to announce an investment in and strategic partnership with European medical cannabis company, GreenLight Pharmaceuticals Ltd. ("GreenLight Pharmaceuticals" or "GreenLight"). GreenLight, which was founded in 2014 and is headquartered in Dublin, Ireland , is a vertically-integrated medical cannabis company with a clinical research and development operation led by Dr. James Linden , a seed genetics program, cultivation operations, and CBD brand and distribution operations.

  • SOL Global Provides Update on Operations, Strategy and Financials
    CNW Group5 months ago

    SOL Global Provides Update on Operations, Strategy and Financials

    Announces Upcoming Hemp Strategy and Investment in OG DNA Genetics Inc. TORONTO , Dec. 12, 2018 /CNW/ - SOL Global Investments Corp. ("SOL" or the "Company") (SOL.CN) (9SB.F) (SOLCF) is pleased to provide a corporate update on its operations, strategy and current financial position including the announcement of a strategic partnership with one of the most widely recognized and acclaimed global brands in cannabis breeding and genetics, OG DNA Genetics Inc. ("DNA Genetics"). The transaction with DNA Genetics is yet another strategic investment that further enhances our U.S. cannabis portfolio," said SOL Chief Investment Officer Andy DeFrancesco .

  • CNW Group6 months ago

    SOL Global Investments CEO Issues Statement on Sale of Latin American Assets

    SOL Global Investments Corp. today makes a statement on the September 27, 2018 sale of it's Latin America operations, LATAM Holdings Inc., to Aphria Inc. TORONTO , Dec. 5, 2018 /CNW/ - SOL Global Investments Corp. ("SOL Global" or the "Company") (SOL.CN) (SOLCF) (9SB.F) today makes a statement on the September 27, 2018 sale of its Latin American operations, LATAM Holdings Inc., to Aphria Inc.

  • SOL Global Investments Reports Record Financial Results for Six-Months Ended September 30, 2018
    CNW Group6 months ago

    SOL Global Investments Reports Record Financial Results for Six-Months Ended September 30, 2018

    "During the period, SOL has made important changes in repositioning the Company to take advantage of the interest in the cannabis sector by identifying and developing cultivation assets, branded products and ancillary opportunities in the U.S., Europe and other South American markets. The accounting IFRS gain on the sale of LATAM totalled $203 million .